Companies: 11,030     total market cap: $152.593 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
โ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Neurocrine Biosciences
NBIX
#1416
Rank
$15.91 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
$158.29
Share price
-0.45%
Change (1 day)
25.08%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $1.49 Billion USD

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are $1.49 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$1.37 B22.09%
2024-12-31$1.12 B10.75%
2023-12-31$1.01 B54.24%
2022-12-31$0.66 B-5.38%
2021-12-31$0.69 B14.79%
2020-12-31$0.60 B-9.06%
2019-12-31$0.66 B30.59%
2018-12-31$0.51 B15.03%
2017-12-31$0.44 B787.2%
2016-12-31$50.2 M-0.24%
2015-12-31$50.33 M46.59%
2014-12-31$34.33 M0.2%
2013-12-31$34.26 M-17.64%
2012-12-31$41.6 M-46.85%
2011-12-31$78.28 M-37.41%
2010-12-31$0.12 B87.06%
2009-12-31$66.86 M-17.87%
2008-12-31$81.4 M-48.46%
2007-12-31$0.15 B110.72%
2006-12-31$74.96 M-19.41%
2005-12-31$93.01 M-25.82%
2004-12-31$0.12 B-23.47%
2003-12-31$0.16 B287.45%
2002-12-31$42.28 M17.6%
2001-12-31$35.95 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$117.21 B 7,720.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$143.07 B 9,445.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$85.37 B 5,596.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
$0.82 B-44.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
$43.82 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$0.85 B-42.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
$8.21 M-99.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
$9.87 B 559.10%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com